Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-17

Clinical Trial Update: New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.

View source ↗

Summary

An exploratory qualitative study evaluating new-onset chronic pelvic pain in transgender individuals using testosterone therapy; recruitment is underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Transgender Persons, Pelvic Pain | Status: RECRUITING